We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Agios Pharmaceuticals has filed for regulatory approval of its drug Mitapivat (PYRUKYND) to treat adult patients with both non-transfusion-dependent and transfusion-dependent forms of alpha- or ...
As of 10:24:17 AM EDT. Market Open. CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback